Lower systolic blood pressure, C-reactive protein (CRP), blood glycemic parameters (glucose and insulin), lipid profile (lower triglyceride, higher HDL-C), anthropometric measurements linked obesity (waist circumference, body mass index) have been shown (4)
the single controlled insomnia trial most often cited showed modest effects at best
The MCH bacterial group showed a significant decrease compared to the control (74.03 1.270 Vs 108.6 2.452, P = 0.0072**), also the 1st group showed a significant decrease compared with the control (61.57 2.194 Vs 108.6 2.452, P = 0.0097**), the 2nd injection group showed nonsignificant increased compared to control (160.4 13.35 Vs 108.6 2.452, P = 0.0686), also the Vacc + Bac showed non-significant decreased (68.87 10.35 Vs 108.6 2.452, P = 0.0638), the 1st injection showed non-significant decreased comparing with bacteria (61.57 2.194 Vs 74.03 1.270, P = 0.0581), while the 2nd injection showed significantly increased compared with a bacterial group (160.4 13.35 Vs 74.03 1.270, P = 0.0198*), furthermore the Vacc + Bac showed non-markedly decreased comparing with a bacterial group (68.87 10.35 Vs 74.03 1.270, P = 0.8478) (Fig
Be smart and anticipate the reaction any time you introduce a new treatment